Investor Presentaiton

Annual Assessment ● Assessments Prescription drug manufacturers who meet the requirements of a reporting manufacturer, as defined in OAR 836-200-0505, will be required to pay an annual assessment of $400. Reporting Assessment ● Reporting manufacturers that file reports are required to pay an additional report assessment for each report filed. The amount of the report assessment will vary depending on the number of reports the department receives each year. 34

View entire presentation